Viscosity Drift after packaging change: manufacturing vs lab root cause assessment


Published on 30/12/2025

Assessing Viscosity Drift Following a Packaging Change: Root Cause Investigation in Pharma Manufacturing

Recently, a manufacturing facility encountered repeated viscosity drift in dental dosage forms following a change in packaging materials. This issue not only risks product effectiveness but also invites scrutiny during regulatory inspections. This article provides a comprehensive framework for professionals in pharmaceutical manufacturing and quality assurance to conduct a thorough investigation, identify root causes, and implement effective corrective actions.

By the end of this article, readers will be equipped to systematically assess viscosity drift incidents, apply effective root cause analysis tools, and enhance their CAPA strategies—all while ensuring continued compliance with GMP and regulatory expectations.

Symptoms/Signals on the Floor or in the Lab

Symptoms of viscosity drift may manifest as unexpected changes in product texture, flow, or stability. Manufacturing teams and quality control laboratories should be vigilant for the following signals:

  • Inconsistencies in Batch Records: Variations in viscosity measurements compared to historical data.
  • Deviation Reports: Increased occurrences of OOS (Out of Specification) results during routine quality
checks.
  • Consumer Complaints: Feedback from end-users regarding product performance issues, such as difficulty in application or stability.
  • Changes in Packaging Within Production: Adjustments in container materials or closures noted in production logs during the affected period.
  • Documenting these observations is critical to establishing a clear trajectory for investigation and analysis.

    Explore the full topic: Dosage Forms & Drug Delivery Systems

    Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

    Identifying the potential causes of viscosity drift requires a structured approach encompassing multiple factors. These can be categorized as follows:

    Category Potential Causes
    Materials Variation in raw material properties, incompatible packaging materials, or variance in supplier quality.
    Method Inconsistent mixing procedures or temperature control during the production process.
    Machine Equipment calibration issues, improper maintenance, or mechanical failures contributing to varying processing conditions.
    Man Lack of training or oversight in production and quality control teams.
    Measurement Deficient measurement techniques or equipment leading to erroneous viscosity readings.
    Environment Fluctuations in ambient conditions during production (temperature, humidity) that could affect formulations.

    By evaluating these categories, teams can focus their investigation on the most likely contributors to viscosity drift.

    Immediate Containment Actions (first 60 minutes)

    Upon discovering viscosity drift, immediate containment is paramount to minimize risk and ensure compliance. Recommended actions include:

    • Stop Production: Halt ongoing production activities related to the affected batch or formulations.
    • Isolation of Affected Batches: Secure and quarantine all production lots following the packaging change that exhibit signs of viscosity drift.
    • Collect Samples: Gather samples from both the affected batches and non-affected historical batches for comparative analysis.
    • Notify Stakeholders: Inform relevant departments (QA, R&D, Production) to ensure transparency and coordinated efforts in the investigation.
    • Documentation: Begin detailed documentation of observations, containment actions, and any deviations noted.

    These immediate steps lay the groundwork for further investigation and ensure compliance during FDA inspections or review by other regulatory bodies.

    Investigation Workflow (data to collect + how to interpret)

    Following containment, an organized investigation workflow is essential. Key steps include:

    1. Data Collection: Gather quantitative and qualitative data including:
      • Viscosity measurements from both affected and unaffected batches.
      • Batch records, including production parameters and raw material certificates of analysis.
      • Equipment maintenance logs and calibration certificates.
      • Environmental monitoring data during production.
    2. Data Interpretation: Analyze collected data to identify trends. Common techniques include:
      • Statistical Process Control (SPC) charts to uncover deviations.
      • Root cause identification based on historical versus current data.
      • Comparison of viscosity measurements against established specifications.
    3. Cross-functional Review: Engage relevant departments to assess findings collectively, incorporating insights from manufacturing, quality, and regulatory perspectives.

    This structured approach aids in developing a comprehensive understanding of the factors influencing viscosity and streamlines future actions.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

    Determining the root cause of viscosity drift can be effectively managed using various analytical tools. Here’s a brief overview of three commonly used techniques:

    • 5-Why Analysis: Simplistic yet powerful, the 5-Why tool involves asking “why” up to five times to reach the core issue. Suitable for straightforward problems.
    • Fishbone Diagram (Ishikawa): Useful for categorizing potential causes across materials, methods, machines, etc. This visual tool is effective in brainstorming sessions with cross-functional teams.
    • Fault Tree Analysis (FTA): A more rigorous approach that involves diagrammatic representation of the logical relationships between failures. It’s applicable for complex issues with multiple interdependencies.

    Select the most appropriate tool based on the complexity of the deviation and the resources available for investigation. A combination of these tools might be appropriate depending on the findings.

    CAPA Strategy (correction, corrective action, preventive action)

    A robust Corrective and Preventive Action (CAPA) strategy ensures that the viscosity drift issue is not only resolved but also prevented in the future. This strategy consists of three primary components:

    • Correction: Immediate actions taken to rectify the identified issues. This may include rework of affected batches or adjustments in production methods.
    • Corrective Action: Long-term solutions implemented based on the root cause analysis. Actions may include retraining staff, updating SOPs (Standard Operating Procedures), or equipment upgrades.
    • Preventive Action: Steps taken to avoid recurrence of similar issues, such as regular audits of packaging suppliers or enhanced environmental controls in production areas.

    Documenting these steps clearly is vital for compliance and satisfactory closure of CAPA actions during regulatory inspections.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    To ensure ongoing control over viscosity post-investigation, it is critical to reinforce your control strategy:

    • Statistical Process Control (SPC): Implement SPC charts for real-time monitoring of viscosity measurements. This allows for immediate identification of trends indicating deviation.
    • Regular Sampling: Schedule routine sampling during production to identify variance in viscosity levels proactively.
    • Alarm Systems: Integrate alarm systems that trigger alerts when viscosity or other critical quality parameters fall outside predetermined limits.
    • Verification Protocols: Establish verification measures to confirm that all new procedures and changes are effective. This can include periodic review of process data and calibration checks.

    These strategies strengthen the company’s quality assurance processes and help maintain compliance with regulatory expectations.

    Related Reads

    Validation / Re-qualification / Change Control impact (when needed)

    Following a deviation investigation, it’s essential to consider the impact of validations, re-qualifications, and change controls:

    • Validation: Any changes to processes or materials resulting from the investigation may necessitate re-validation of affected processes to ensure they meet established criteria.
    • Re-qualification: Equipment involved in production that showed issues during viscosity drift may require re-qualification to ensure ongoing compliance and performance.
    • Change Control: All changes made within the investigation’s context should be documented under a change control process, including approval from relevant departments.

    Applying a structured change control protocol mitigates future risks associated with packaging alterations or process adjustments.

    Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

    When preparing for an inspection by regulatory bodies, such as the FDA or EMA, documentation is crucial. Key evidence to keep ready includes:

    • Batch Records: Complete records detailing the production process, including materials used, conditions experienced, and results.
    • Deviation Logs: Records of all deviations related to viscosity, showing how they were handled and the outcomes.
    • CAPA Documentation: Comprehensive documentation of the CAPA process undertaken in response to the viscosity drift.
    • Training Records: Documentation of employee training and qualifications related to the new procedures resulting from the investigations.

    Storing organized and accessible records fosters a culture of compliance and empowers teams to provide necessary evidence during regulatory inspections.

    FAQs

    What is viscosity drift?

    Viscosity drift refers to an unexpected change in the viscosity of a product, which can result from variations in formulation or production processes.

    How can I prevent viscosity drift after a packaging change?

    Implement thorough validation processes, enforce controlled environmental conditions, and utilize robust CAPA strategies to mitigate risks associated with viscosity drift.

    What are the initial steps in managing a viscosity drift incident?

    Immediate containment actions include halting production, isolating affected batches, and initiating a root cause investigation.

    Is SPC beneficial for viscosity control?

    Yes, Statistical Process Control (SPC) is crucial for real-time monitoring of viscosity metrics, ensuring deviations are caught early.

    What regulatory agencies should I be aware of regarding viscosity standards?

    Key regulatory agencies include the FDA, EMA, and MHRA, all of which have guidelines regarding viscosity and product consistency.

    How will implementing a CAPA process help with viscosity issues?

    A well-implemented CAPA process addresses the root cause, provides corrective actions, and sets preventive measures, reducing the risk of recurrence.

    Should I document every change in the manufacturing process?

    Yes, maintaining thorough documentation of all changes under a change control process is essential for regulatory compliance and quality assurance.

    What common tools aid in root cause analysis?

    Tools like 5-Why analysis, Fishbone diagrams, and Fault Tree Analysis are commonly utilized for effective root cause analysis.

    How does training impact viscosity control?

    Ensuring that staff are adequately trained in new procedures and methodologies can significantly reduce the risk of human error, which is a common cause of viscosity drift.

    What documentation is crucial during an inspection?

    Important documentation includes batch records, deviation logs, CAPA reports, and employee training records to demonstrate compliance with GMP and regulatory expectations.

    Can viscosity drift affect product stability?

    Yes, significant viscosity drift can lead to product stability issues, potentially affecting efficacy and safety, thereby necessitating immediate attention.

    What steps should I take if an investigation leads to a finding?

    Develop an appropriate CAPA response based on the investigation findings, ensure all changes are documented, and monitor outcomes to verify effectiveness.

    Pharma Tip:  Phase Separation in cream manufacturing: GMP investigation and CAPA strategy